SCHEMBL3676541

SCHEMBL3676541

O=C(O)[C@@H]1C[C@H](CO)CN1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ARG1 P05089 2/20 0.59
CYP1A2 P05177 3/20 0.54
ALOX15 P16050 3/20 0.54
CYP2C19 P33261 3/20 0.54
CYP2D6 P10635 3/20 0.54
SLC1A3 P43003 1/20 0.54
SLC1A2 P43004 1/20 0.54
SLC1A1 P43005 1/20 0.54
DPP4 P27487 1/20 0.45
MEN1 O00255 3/20 0.44
KMT2A Q03164 3/20 0.44
THRB P10828 2/20 0.44
ALDH1A1 P00352 1/20 0.44
GRIN2D O15399 1/20 0.44
GRIN3B O60391 1/20 0.44
GRIA1 P42261 1/20 0.44
GRIA2 P42262 1/20 0.44
GRIA3 P42263 1/20 0.44
GRIA4 P48058 1/20 0.44
GRIN1 Q05586 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1476315 1.00 ARG1 (0.59) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL4302105 1.00 ARG1 (0.59) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL3675363 1.00 ARG1 (0.59) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL1512874 1.00 ARG1 (0.59) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL3675362 1.00 ARG1 (0.59) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL1512877 1.00 ARG1 (0.59) ARG1CYP1A2ALOX15CYP2C19CYP2D6
Hydrochloric Acid SCHEMBL1914280 0.98 ARG1 (0.58) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL7537502 0.82 ARG1 (0.44) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL7694066 0.81 ARG1 (0.44) ARG1CYP1A2ALOX15CYP2C19CYP2D6
SCHEMBL4950542 0.81 ARG1 (0.58) ARG1CYP1A2ALOX15CYP2C19CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-117815381-A Carbohydrate modified particles and particle formulations for modulating immune responses 西北大学 2024-04-05 CN claimed
US-20230058412-A1 Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response NORTHWESTERN UNIVERSITY 2023-02-23 US claimed
US-20210205443-A1 Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response NORTHWESTERN UNIVERSITY 2021-07-08 US claimed
CN-108024969-A Carbohydrate-modified particles and particle formulations for modulating immune responses 西北大学 2018-05-11 CN claimed
EP-3302446-A1 CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE Northwestern University (US) 2018-04-11 EP claimed
US-20160346382-A1 CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE NORTHWESTERN UNIVERSITY (US) 2016-12-01 US claimed
WO-2016191723-A1 CARBOHYDRATE-MODIFIED PARTICLES AND PARTICULATE FORMULATIONS FOR MODULATING AN IMMUNE RESPONSE NORTHWESTERN UNIVERSITY (US) 2016-12-01 WO claimed
CN-117815381-A Carbohydrate modified particles and particle formulations for modulating immune responses 西北大学 2024-04-05 CN disclosed
US-20230058412-A1 Carbohydrate-Modified Particles and Particulate Formulations for Modulating an Immune Response NORTHWESTERN UNIVERSITY 2023-02-23 US disclosed
EP-4099849-A1 COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE Société des Produits Nestlé S.A. (CH) 2022-12-14 EP disclosed
EP-4033922-A1 COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF WEIGHT LOSS Société des Produits Nestlé S.A. (CH) 2022-08-03 EP disclosed
WO-2022087630-A1 INHIBITORS OF AMINO ACID TRANSPORT ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2022-04-28 WO disclosed
WO-2021156181-A1 COMPOSITIONS AND METHODS FOR THE IMPROVEMENT AND MAINTENANCE OF GLUCOSE METABOLISM IN CHILDHOOD AND ADOLESCENCE Société des Produits Nestlé S.A. (CH) 2021-08-12 WO disclosed
CN-104771513-A Traditional Chinese medicine composition for treating cholecystitis WANG YULING 2015-07-15 CN disclosed
CN-104758622-A Liver soothing and qi regulating preparation for patient with cholecystitis and preparation method of liver soothing and qi regulating preparation WANG YULING 2015-07-08 CN disclosed
US-7727530-B2 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody SALAMA ZOSER B 2010-06-01 US disclosed
CN-1997365-A Anticancer composition containing proline or its derivative and antitumor antibody SALAMA ZOSER B (DE) 2007-07-11 CN disclosed
EP-1765328-A1 ANTI-CANCER COMPOSITION COMPRISING PROLINE OR ITS DERIVATIVES AND AN ANTI-TUMOUR ANTIBODY Salama, Zoser B. (DE) 2007-03-28 EP disclosed
WO-2005120495-A1 ANTI-CANCER COMPOSITION COMPRISING PROLINE OR ITS DERIVATIVES AND AN ANTI-TUMOUR ANTIBODY SALAMA ZOSER B (DE) 2005-12-22 WO disclosed
US-20050276810-A1 Anti-cancer composition comprising proline or its derivatives and an anti-tumour antibody SALAMA ZOSER B 2005-12-15 US disclosed